Rivaroxaban (10mg) & ROXARIVABEN 10 Mg : STERIS PHARMA

ROXARIVABEN 10 Mg 

Rivaroxaban (10mg)

Rivaroxaban 10 mg, sold under the brand name ROXARIVABEN 10 Mg, is an oral anticoagulant medication. Rivaroxaban is commonly prescribed to prevent and treat blood clots in patients with conditions such as atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). The 10 mg dosage is specifically indicated for various therapeutic purposes, providing a balance between efficacy and safety.

Uses

Rivaroxaban (10mg) is used for multiple indications, including:

1. Prevention of Stroke and Systemic Embolism: In patients with non-valvular atrial fibrillation, Rivaroxaban helps reduce the risk of stroke and systemic embolism by preventing blood clots from forming in the heart and traveling to other parts of the body.
2. Treatment of Deep Vein Thrombosis (DVT): It is effective in treating DVT, a condition where blood clots form in the deep veins of the legs, leading to pain and swelling.
3. Treatment of Pulmonary Embolism (PE): Rivaroxaban is also used to treat PE, a serious condition where blood clots travel to the lungs, causing chest pain, difficulty breathing, and other complications.
4. Prophylaxis of DVT and PE: Following hip or knee replacement surgery, Rivaroxaban (10mg) is used to prevent the formation of DVT and PE, as these surgeries increase the risk of blood clots.
5. Secondary Prevention of Recurrent DVT and PE: It is prescribed to prevent the recurrence of DVT and PE in patients who have already experienced these conditions.

Dosage

The dosage of Rivaroxaban (10mg) varies based on the indication:

1. Atrial Fibrillation: The typical dosage for preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation is 20 mg once daily with the evening meal. For patients with renal impairment, the dose may be reduced to 15 mg once daily.
2. DVT and PE Treatment: The initial treatment for DVT and PE typically starts with 15 mg twice daily for the first 21 days, followed by 20 mg once daily.
3. DVT and PE Prophylaxis Post-Surgery: For patients undergoing hip or knee replacement surgery, the recommended dose is 10 mg once daily, starting 6-10 hours after surgery. The duration of treatment is typically 35 days for hip replacement and 12 days for knee replacement.
4. Recurrent DVT and PE Prevention: For long-term prevention of recurrent DVT and PE, the dose is 10 mg once daily after at least 6 months of initial anticoagulation therapy.

Side Effects

While Rivaroxaban (10mg) is effective in preventing and treating blood clots, it may cause some side effects. Common side effects include:

1. Bleeding: The most significant side effect is bleeding, which can range from minor bruising to severe, life-threatening hemorrhages.
2. Gastrointestinal Issues: Some patients may experience nausea, vomiting, diarrhea, or stomach pain.
3. Anemia: Rivaroxaban can cause a decrease in red blood cells, leading to anemia.
4. Liver Enzyme Changes: Abnormal liver function tests may occur in some patients.
5. Allergic Reactions: Although rare, some patients may experience allergic reactions such as rash, itching, and swelling.

Price

The price of ROXARIVABEN 10 Mg can vary based on the region, pharmacy, and insurance coverage. On average, a monthly supply of Rivaroxaban (10mg) can range from $300 to $500 without insurance. Many insurance plans cover a portion of the cost, and patient assistance programs may be available to help reduce out-of-pocket expenses.

Conclusion

Rivaroxaban (10mg), marketed as ROXARIVABEN 10 Mg, is a highly effective anticoagulant used to prevent and treat various thromboembolic conditions. Its uses range from preventing stroke in atrial fibrillation patients to treating and preventing DVT and PE. While it offers significant benefits, it is essential to use this medication under the guidance of a healthcare provider due to the potential risk of bleeding and other side effects. Patients should follow their prescribed dosage regimen and consult their healthcare provider regularly to ensure the safe and effective use of Rivaroxaban. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW